On Friday, Eyenovia Inc (NASDAQ: EYEN) opened lower -8.65% from the last session, before settling in for the closing price of $0.82. Price fluctuations for EYEN have ranged from $0.50 to $3.64 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 100.00% over the past five years. Company’s average yearly earnings per share was noted -32.58% at the time writing. With a float of $45.05 million, this company’s outstanding shares have now reached $45.55 million.
Let’s look at the performance matrix of the company that is accounted for 57 employees.
Eyenovia Inc (EYEN) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Eyenovia Inc is 16.37%, while institutional ownership is 14.67%. The most recent insider transaction that took place on Mar 28 ’24, was worth 98,000. In this transaction 10% Owner of this company bought 100,000 shares at a rate of $0.98, taking the stock ownership to the 5,430,715 shares. Before that another transaction happened on Mar 19 ’24, when Company’s 10% Owner bought 50,000 for $1.23, making the entire transaction worth $61,500. This insider now owns 5,330,715 shares in total.
Eyenovia Inc (EYEN) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -32.58% per share during the next fiscal year.
Eyenovia Inc (NASDAQ: EYEN) Trading Performance Indicators
Check out the current performance indicators for Eyenovia Inc (EYEN). In the past quarter, the stock posted a quick ratio of 0.61. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4039.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.76, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -0.89 in one year’s time.
Technical Analysis of Eyenovia Inc (EYEN)
Eyenovia Inc (NASDAQ: EYEN) saw its 5-day average volume 1.43 million, a positive change from its year-to-date volume of 1.11 million. As of the previous 9 days, the stock’s Stochastic %D was 33.36%. Additionally, its Average True Range was 0.13.
During the past 100 days, Eyenovia Inc’s (EYEN) raw stochastic average was set at 12.03%, which indicates a significant increase from 7.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 200.40% in the past 14 days, which was higher than the 140.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9243, while its 200-day Moving Average is $1.4930. Nevertheless, the first resistance level for the watch stands at $0.8299 in the near term. At $0.9100, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9500. If the price goes on to break the first support level at $0.7098, it is likely to go to the next support level at $0.6698. The third support level lies at $0.5897 if the price breaches the second support level.
Eyenovia Inc (NASDAQ: EYEN) Key Stats
There are currently 53,871K shares outstanding in the company with a market cap of 40.40 million. Presently, the company’s annual sales total 4 K according to its annual income of -27,260 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,970 K.
